Suparat Charoenfuprasert

Title: Suparat Charoenfuprasert: Innovator in Ovarian Cancer Diagnosis

Introduction

Suparat Charoenfuprasert is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the area of ovarian cancer. With a total of 2 patents, his work focuses on innovative methods for diagnosing and treating this critical health issue.

Latest Patents

Suparat's latest patents include a method for the diagnosis of the presence of ovarian cancer. This invention provides an isolated antigen polypeptide that can be expressed in a subject with ovarian cancer. It also outlines the diagnosis of ovarian cancer using this antigen polypeptide and discusses the prevention and/or treatment of ovarian cancer by suppressing the gene of the antigen polypeptide. Another significant patent is an antigen polypeptide for the diagnosis and/or treatment of ovarian cancer, which similarly provides an isolated antigen polypeptide that can be expressed in a subject with ovarian cancer.

Career Highlights

Throughout his career, Suparat has worked with esteemed institutions such as Taipei Medical University and the National Health Research Institutes. His research and innovations have contributed to advancements in medical diagnostics and treatment options for ovarian cancer.

Collaborations

Suparat has collaborated with notable colleagues, including Sy-Jye Leu and Neng-Yao Shih, who have played a role in his research endeavors.

Conclusion

Suparat Charoenfuprasert's work in the field of ovarian cancer diagnosis exemplifies the impact of innovative thinking in medicine. His patents not only advance diagnostic methods but also pave the way for potential treatments, showcasing the importance of research in improving patient outcomes.